Durable Major Response With Pazopanib in Recurrent, Heavily Pretreated Metastatic Esthesioneuroblastoma Harboring a Fumarate Hydratase Mutation.

Competing Interests: The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO’s conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/po/author-center. Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments). Joseph J. Drabick Consulting or Advisory Role: Sanofi/Aventis No other potential conflicts of interest were reported.Joseph J. Drabick Consulting or Advisory Role: Sanofi/Aventis No other potential conflicts of interest were reported.Joseph J. Drabick Consulting or Advisory Role: Sanofi/Aventis No other potential conflicts of interest were reported.